Vanguard Fiduciary Trust
GOCO

Vanguard Fiduciary Trust’s GoHealth GOCO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-52,518
Closed -$79.3K – 4112
2026
Q1 		$79.3K Buy
+52,518
New +$100K ﹤0.01% 3751

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Fiduciary Trust's GOCO Position: Q2 2026 in Review

Vanguard Fiduciary Trust sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 52,518 shares — an estimated $79.3K sold.

Vanguard Fiduciary Trust first reported a position in GOCO in Q1 2026 and held it in 1 quarter. The position peaked at $79.3K in Q1 2026. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Vanguard Fiduciary Trust reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Vanguard Fiduciary Trust sold 52,518 GoHealth shares in Q2 2026, an estimated $79.3K.
  • Vanguard Fiduciary Trust first reported a position in GoHealth in Q1 2026 and held it in 1 quarter.
  • Vanguard Fiduciary Trust's GoHealth position peaked at $79.3K in Q1 2026.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.